Skip to main content

Pharma-Bio Serv, Inc.

corporate_fare Company Profile

Pharma-Bio Serv, Inc.

PBSV·OTC·Trade & Services·CIK 0001304161

Pharma-Bio Serv, Inc. is a Delaware corporation organized on January 14, 2004, providing technical compliance consulting services. The company operates in Puerto Rico, the United States, Europe, and Brazil under the name Pharma-Bio Serv. It serves the pharmaceutical, chemical, biotechnology, medical devices, cosmetic, and food industries, as well as allied products companies. Pharma-Bio Serv is a regulatory affairs, quality, compliance, and technology transfer services consulting firm with headquarters in Puerto Rico. It primarily services the Puerto Rico, United States, and European markets, and to a lesser extent, the Brazilian market. The company offers a broad range of compliance-related consulting services. Its consulting team consists of experienced engineering and life science professionals, former quality assurance managers and directors, former health agency officials, and professionals with bachelors, masters, and doctorate degrees in health sciences and engineering. Pharma-Bio Serv maintains established relationships with major pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico and the United States.

Pharma-Bio Serv, Inc. (OTC:PBSV) is a publicly traded company in the Trade & Services sector. Wiseek monitors PBSV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Pharma-Bio Serv Discloses Material Related-Party AI Investment and Sets Annual Meeting Agenda
  • Pharma-Bio Serv Declares Substantial Cash Dividend, Boosts Liquidity Despite Revenue Dip
  • Pharma-Bio Serv Amends 10-K to Disclose Significant Related-Party AI Investment and Executive Compensation
  • Pharma-Bio Serv Declares Substantial Special Dividend Alongside Full-Year Results
  • Pharma-Bio Serv Reports Reduced Net Loss, Improved Margins Amidst Significant Cash Decline and Tax Grant Uncertainty

Financial Snapshot

Fiscal year ended October 31, 2025
Revenue
$9M
Net Income
-$100.46K
Diluted EPS
-$0.00
Op. Cash Flow
-$214.89K
Free Cash Flow
-$221.53K
Gross Profit
$2.91M
Operating Income
-$637.66K
Cash & Equivalents
$3.38M
Debt / Equity
0.00×
Net Margin
-1.1%
Shares Outstanding
22.91M sh
Source: 10-K · filed 2026-02-27 · accession 0001654954-26-001674
Browse all tickers starting with P →
$0.565
52-week range · as of 2026-04-16 $0.3127 – $1.36
Market cap
$12.94M
Volume
1K (0.3× avg)
3-mo avg 3.9K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PBSV - Latest Insights

PBSV
Apr 16, 2026, 4:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.565 info
Change: +$0.065 (+13%) info
Market Cap: $12.939M info
PBSV
Mar 17, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.480
Real-time Price: $0.565 info
Change: +$0.085 (+18%) info
Market Cap: $12.939M info
PBSV
Feb 27, 2026, 4:16 PM EST
Filing Type: 10-K/A
Importance Score:
8
Price at Filing: $0.490
Real-time Price: $0.565 info
Change: +$0.075 (+15%) info
Market Cap: $12.939M info
PBSV
Jan 29, 2026, 5:07 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.54056
Real-time Price: $0.565 info
Change: +$0.02444 (+5%) info
Market Cap: $12.939M info
PBSV
Jan 29, 2026, 4:49 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $0.54056
Real-time Price: $0.565 info
Change: +$0.02444 (+5%) info
Market Cap: $12.939M info